Kevin Caliendo
Stock Analyst at UBS
(4.44)
# 354
Out of 4,732 analysts
161
Total ratings
70.13%
Success rate
11.57%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Buy | $27 → $14 | $10.00 | +40.00% | 2 | Jan 16, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Buy | $35 → $27 | $18.77 | +43.85% | 9 | Dec 3, 2024 | |
| CVS CVS Health | Maintains: Neutral | $60 → $62 | $52.62 | +17.83% | 6 | Nov 7, 2024 | |
| COR Cencora | Maintains: Buy | $275 → $285 | $242.05 | +17.74% | 1 | Nov 7, 2024 | |
| OMI Owens & Minor | Maintains: Buy | $28 → $25 | $14.58 | +71.47% | 4 | Nov 5, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $134 → $139 | $126.27 | +10.08% | 15 | Nov 4, 2024 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $9 → $12 | $14.58 | -17.70% | 6 | Oct 30, 2024 | |
| DGX Quest Diagnostics | Maintains: Neutral | $165 → $166 | $151.20 | +9.79% | 12 | Oct 23, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Neutral | $9 → $10 | $12.52 | -20.13% | 14 | Oct 17, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $680 → $650 | $509.76 | +27.51% | 11 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $282.63 | -11.55% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $7.5 | $7.99 | -6.13% | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $8.5 | $4.57 | +86.00% | 3 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $72 | $73.22 | -1.67% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $270 | $238.56 | +13.18% | 1 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $12 | $9.55 | +25.65% | 2 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $620 → $630 | $592.57 | +6.32% | 13 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $280 → $320 | $224.23 | +42.71% | 17 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $385 → $400 | $283.99 | +40.85% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $26 | $19.83 | +31.11% | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $350 → $380 | $286.21 | +32.77% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $62.25 | +26.91% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $26 | $22.43 | +15.92% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $385.29 | +49.24% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $147.03 | +22.42% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $9.09 | +692.08% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $21.92 | -49.82% | 4 | May 4, 2021 |
Evolent Health
Jan 16, 2025
Maintains: Buy
Price Target: $27 → $14
Current: $10.00
Upside: +40.00%
DENTSPLY SIRONA
Dec 3, 2024
Maintains: Buy
Price Target: $35 → $27
Current: $18.77
Upside: +43.85%
CVS Health
Nov 7, 2024
Maintains: Neutral
Price Target: $60 → $62
Current: $52.62
Upside: +17.83%
Cencora
Nov 7, 2024
Maintains: Buy
Price Target: $275 → $285
Current: $242.05
Upside: +17.74%
Owens & Minor
Nov 5, 2024
Maintains: Buy
Price Target: $28 → $25
Current: $14.58
Upside: +71.47%
Cardinal Health
Nov 4, 2024
Maintains: Buy
Price Target: $134 → $139
Current: $126.27
Upside: +10.08%
Alignment Healthcare
Oct 30, 2024
Maintains: Neutral
Price Target: $9 → $12
Current: $14.58
Upside: -17.70%
Quest Diagnostics
Oct 23, 2024
Maintains: Neutral
Price Target: $165 → $166
Current: $151.20
Upside: +9.79%
Walgreens Boots Alliance
Oct 17, 2024
Maintains: Neutral
Price Target: $9 → $10
Current: $12.52
Upside: -20.13%
UnitedHealth Group
Oct 16, 2024
Maintains: Buy
Price Target: $680 → $650
Current: $509.76
Upside: +27.51%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $282.63
Upside: -11.55%
Aug 15, 2024
Maintains: Neutral
Price Target: $9 → $7.5
Current: $7.99
Upside: -6.13%
Aug 9, 2024
Maintains: Neutral
Price Target: $9 → $8.5
Current: $4.57
Upside: +86.00%
Aug 7, 2024
Maintains: Neutral
Price Target: $75 → $72
Current: $73.22
Upside: -1.67%
Aug 2, 2024
Maintains: Buy
Price Target: $260 → $270
Current: $238.56
Upside: +13.18%
May 23, 2024
Maintains: Neutral
Price Target: $30 → $12
Current: $9.55
Upside: +25.65%
May 8, 2024
Maintains: Buy
Price Target: $620 → $630
Current: $592.57
Upside: +6.32%
Apr 15, 2024
Maintains: Neutral
Price Target: $280 → $320
Current: $224.23
Upside: +42.71%
Mar 8, 2024
Maintains: Buy
Price Target: $385 → $400
Current: $283.99
Upside: +40.85%
Jan 5, 2024
Initiates: Neutral
Price Target: $26
Current: $19.83
Upside: +31.11%
Dec 21, 2023
Maintains: Neutral
Price Target: $350 → $380
Current: $286.21
Upside: +32.77%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $62.25
Upside: +26.91%
Aug 23, 2023
Maintains: Neutral
Price Target: $29 → $26
Current: $22.43
Upside: +15.92%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $385.29
Upside: +49.24%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $147.03
Upside: +22.42%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $9.09
Upside: +692.08%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $21.92
Upside: -49.82%